Sanofi (SNY) Projected to Post Quarterly Earnings on Thursday

Sanofi ( NASDAQ:SNY – Get Free Report ) will likely be posting its quarterly earnings results before the market opens on Thursday, April 24th. Analysts expect Sanofi to post earnings of $0.87 per share and revenue of $9.

79 billion for the quarter. Sanofi ( NASDAQ:SNY – Get Free Report ) last released its earnings results on Thursday, January 30th. The company reported $0.



70 EPS for the quarter, meeting the consensus estimate of $0.70. Sanofi had a net margin of 12.

77% and a return on equity of 25.61%. On average, analysts expect Sanofi to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Sanofi Stock Down 0.1 % NASDAQ SNY opened at $50.56 on Thursday.

Sanofi has a twelve month low of $45.22 and a twelve month high of $60.12.

The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.14 and a current ratio of 1.

46. The stock has a market cap of $127.73 billion, a PE ratio of 20.

31, a PEG ratio of 1.01 and a beta of 0.57.

The firm has a 50-day simple moving average of $54.83 and a 200 day simple moving average of $52.28.

Wall Street Analysts Forecast Growth Read Our Latest Report on Sanofi Institutional Trading of Sanofi A hedge fund recently raised its stake in Sanofi stock. Brighton Jones LLC raised its holdings in Sanofi ( NASDAQ:SNY – Free Report ) by 52.6% in the 4th quarter, according to the company in its most recent filing with the SEC.

The firm owned 5,420 shares of the company’s stock after acquiring an additional 1,869 shares during the quarter. Brighton Jones LLC’s holdings in Sanofi were worth $261,000 as of its most recent SEC filing. 14.

04% of the stock is owned by institutional investors. About Sanofi ( Get Free Report ) Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments.

The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. See Also Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with MarketBeat.com's FREE daily email newsletter .

.